AdamDavidDurbinMDPh.D.
Pediatric Hematology & Oncology • Memphis, TNPediatric Solid Tumor Oncology
Assistant Member Division of Molecular Oncology Department of Oncology Developmental Biology and Solid Tumor Program St. Jude Childrens Research Hospital
Dr. Durbin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
dtrt 5062F
Memphis, TN 38105Phone+1 901-595-7701
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2012 - 2015
University of Toronto Faculty of MedicineClass of 2012
Certifications & Licensure
TN State Medical License 2023 - 2026
MA State Medical License 2015 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Lineage-Selective Dependencies in Pediatric Cancers.K Elaine Ritter, Adam D Durbin
Cold Spring Harbor Perspectives in Medicine. 2024-05-28 - 2 citationsGroup 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier
Nature Communications. 2024-04-25 - 3 citationsSTAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.Nicole Prutsch, Shuning He, Alla Berezovskaya, Adam D Durbin, Neekesh V Dharia
Cell Reports. Medicine. 2024-03-19
Journal Articles
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
Press Mentions
- Targeting Specific Protein Regions Offers a New Treatment Approach in MedulloblastomaApril 26th, 2024
Grant Support
- Dissecting high-risk cell states in neuroblastomaST. JUDE CHILDREN'S RESEARCH HOSPITAL2024–2029
- Targeting EP300, a selective dependency in neuroblastomaST. JUDE CHILDREN'S RESEARCH HOSPITAL2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
